Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Atypical depression: current perspectives.

Łojko D, Rybakowski JK.

Neuropsychiatr Dis Treat. 2017 Sep 20;13:2447-2456. doi: 10.2147/NDT.S147317. eCollection 2017. Review.

2.

Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.

Kessler RC, van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Ebert DD, de Jonge P, Nierenberg AA, Rosellini AJ, Sampson NA, Schoevers RA, Wilcox MA, Zaslavsky AM.

Epidemiol Psychiatr Sci. 2017 Feb;26(1):22-36. doi: 10.1017/S2045796016000020. Epub 2016 Jan 26.

3.

Evidence for Broadening Criteria for Atypical Depression Which May Define a Reactive Depressive Disorder.

Silverstein B, Angst J.

Psychiatry J. 2015;2015:575931. doi: 10.1155/2015/575931. Epub 2015 Jul 14. Review.

4.

Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.

Culpepper L.

Prim Care Companion CNS Disord. 2013;15(5). pii: PCC.13r01515. doi: 10.4088/PCC.13r01515. Epub 2013 Oct 31.

5.

Clinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressions.

Gili M, Roca M, Armengol S, Asensio D, Garcia-Campayo J, Parker G.

PLoS One. 2012;7(10):e48200. doi: 10.1371/journal.pone.0048200. Epub 2012 Oct 26.

6.

Depressed older patients with the atypical features of interpersonal rejection sensitivity and reversed-vegetative symptoms are similar to younger atypical patients.

Sachs-Ericsson N, Selby E, Corsentino E, Collins N, Sawyer K, Hames J, Arce D, Joiner T, Steffens DC.

Am J Geriatr Psychiatry. 2012 Jul;20(7):622-34. doi: 10.1097/JGP.0b013e31822cccff.

7.

Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.

Papakostas GI, Fava M.

Dialogues Clin Neurosci. 2008;10(4):439-51. Review.

8.

An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features.

Pae CU, Masand PS, Peindl K, Mannelli P, Han C, Marks DM, Patkar AA.

Prim Care Companion J Clin Psychiatry. 2008;10(3):205-10.

9.

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.

Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC.

Arch Gen Psychiatry. 1999 May;56(5):431-7.

10.

The pharmacotherapy of depression.

Joffe RT.

J Psychiatry Neurosci. 1991 Jul;16(2 Suppl 1):4-9. Review. No abstract available.

Supplemental Content

Support Center